Sign up to save your podcasts
Or
Share The Potential for Faricimab in the treatment of Central Serous Chorioretinopathy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Potential for Faricimab in the treatment of Central Serous Chorioretinopathy
Dr. Elizabeth Rossin discusses her new study based on genetic background data demonstrating the effect of Faricimab in CSR.
View all episodes
By Various
4.6
1111 ratings
Dr. Elizabeth Rossin discusses her new study based on genetic background data demonstrating the effect of Faricimab in CSR.
More shows like American Journal of Ophthalmology Podcasts Collection
View all
6 Minute English
1,794 Listeners
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
17 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
98 Listeners
White Coat Investor Podcast
2,431 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
The Retina Channel Podcast
11 Listeners
CRST: The Podcast
8 Listeners
Trinity Forum Conversations
212 Listeners
Pupil Pod
10 Listeners
Experts InSight
52 Listeners
RETINA Journal Podcasts
10 Listeners
Ophthalmology Journal
18 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners
Mayo Clinic Ophthalmology Podcast
17 Listeners